Relief Therapeutics Holding AG (RLFTF)

[wonderstocks]

WOW -BARDA anticipates that the research and development activities supported under the BAA will serve to advance candidate medical countermeasures toward licensure or approval by the FDA.

Submission in response to the BAA occurs in two stages. Stage 1 requires submitting a Quad Chart and White Paper; Stage 2 requires submitting a Full Proposal. Before you submit a White Paper or Full Proposal to the BAA, BARDA strongly recommends that you request a TechWatch meeting to discuss your ideas.

BARDA Broad Agency Announcement (BAA-18-100-SOL-00003)
https://www.phe.gov/about/amcg/BARDA-BAA/Pages/default.aspx